Chinese venture capital investment in US technology companies operates within an increasingly complex regulatory environment. This article outlines the key legal considerations for Chinese investors and fund managers.

CFIUS Review Requirements

The Foreign Investment Risk Review Modernization Act expanded CFIUS jurisdiction to cover non-control investments in critical technology companies and real estate transactions near sensitive US government facilities. Chinese investments in technology companies are subject to mandatory declarations for certain transactions involving critical technologies.

Investment Advisers Act Compliance

Chinese fund managers making investments in the US must consider registration requirements under the Investment Advisers Act. Exemptions are available for foreign private advisers with fewer than 15 clients and less than $25 million in assets under management.

Export Control Compliance

Technology transfers to Chinese entities may require export licenses under the Export Administration Regulations. Emerging and foundational technologies identified by the Department of Commerce trigger additional review.

Investment Structure and Document Requirements

Chinese venture capital funds and corporate venture arms investing in US technology companies must select an appropriate investment structure. Direct investments require consideration of US-China tax treaty benefits and potential PFIC considerations. Investments through US-domiciled funds provide liability protection and simplified governance but may trigger additional reporting obligations.

Key documentation for technology VC investments includes the term sheet, stock purchase agreement, investors rights agreement, right of first refusal and co-sale agreement, voting agreement, and amended and restated certificate of incorporation. Chinese investors should pay particular attention to protective provisions, information rights, board observation rights, and most-favored-nation clauses in the transaction documents.

Committee on Foreign Investment in the United States

The Foreign Investment Risk Review Modernization Act of 2018 significantly expanded CFIUS jurisdiction over foreign investments in US businesses. Mandatory declarations are now required for transactions where a foreign government has a substantial interest in the foreign investor and the investment involves critical technologies, critical infrastructure, or sensitive personal data. Chinese state-owned enterprises and entities with ties to Chinese government programs face enhanced scrutiny.

CFIUS review timelines include a 45-day initial review period, a 45-day investigation period, and a potential 15-day presidential review. Chinese investors should prepare mitigation agreements addressing data access, board composition, technology transfer controls, and supply chain security. Not filing when required can result in divestment orders and civil penalties.

Export Control Compliance Considerations

Technology transfers to Chinese entities through VC-backed portfolio companies may trigger Export Administration Regulations license requirements. Emerging technologies including artificial intelligence, quantum computing, semiconductor manufacturing equipment, and biotechnology are subject to enhanced controls. Chinese investors should implement technology control plans restricting access to controlled US technology by Chinese nationals and ensure portfolio company compliance with deemed export rules.

Tax Considerations for Chinese VC Investments

Chinese venture capital funds investing in US portfolio companies face complex US tax considerations. The US-China double tax treaty provides reduced withholding rates on dividends (10 percent for portfolio investments, 5 percent for substantial holdings), interest (10 percent), and royalties (10 percent). However, treaty benefits may be restricted for Chinese state-owned enterprises under the Limitation on Benefits clause. The Foreign Account Tax Compliance Act imposes information reporting and withholding requirements on foreign financial institutions and non-financial foreign entities.

US portfolio companies receiving Chinese VC investment must comply with securities law requirements including Regulation D private placement exemptions, Rule 506 accredited investor verification, and state blue sky law compliance. The JOBS Act provides additional flexibility for emerging growth companies including confidential SEC filing and reduced disclosure requirements.

Fund Structure and ERISA Considerations

Chinese VC funds investing in US companies may be structured as offshore master-feeder arrangements, segregated portfolio companies, or parallel fund vehicles. US tax-exempt investors including pension funds and university endowments require blocker corporation structures to avoid unrelated business taxable income from leveraged investments. Chinese investors should consider the implications of the US Foreign Investment in Real Property Tax Act for real estate-linked technology investments.

Exit Strategies and Regulatory Considerations

Chinese VC investors should plan exit strategies at the time of investment. IPO exits on US exchanges require registration with the SEC and compliance with exchange listing standards. Chinese issuers face additional disclosure requirements under the Holding Foreign Companies Accountable Act. Secondary sale exits to strategic acquirers require consideration of CFIUS jurisdiction extension in change-of-control transactions. Management buyouts and share repurchases provide alternative exit paths.

Securities Law Compliance for Chinese Fund Managers

Chinese fund managers making US investments must consider registration requirements under the US Investment Advisers Act of 1940. The private fund adviser exemption is available for advisers solely managing private funds with less than USD 150 million in assets under management in the United States. The foreign private adviser exemption applies to advisers with fewer than 15 US clients, less than USD 25 million in AUM from US clients, and no US-registered investment adviser clients. Advisers relying on these exemptions must file annual Form ADV reporting. State-level registration requirements may also apply depending on the manager's location and activities. The SEC Division of Examinations conducts periodic examinations of investment advisers including those relying on exemptions, with particular focus on compliance programs, custody requirements, and disclosure obligations. Chinese fund managers should implement comprehensive compliance programs addressing recordkeeping requirements, code of ethics obligations, political contribution restrictions under Rule 206-4, and custody rule compliance for client assets.

Securities Law Considerations for Portfolio Companies

US portfolio companies receiving VC investment from Chinese funds must comply with applicable securities law requirements. Rule 506(b) of Regulation D permits an unlimited amount of capital raising from accredited investors without general solicitation, while Rule 506(c) permits general solicitation with accredited investor verification. Regulation Crowdfunding provides an alternative path for capital raising from non-accredited investors subject to offering limits and disclosure requirements. The Jumpstart Our Business Startups Act provides emerging growth companies with reduced disclosure requirements, confidential SEC filing for IPO registration statements, and testing the waters communications with qualified institutional buyers. Portfolio companies approaching IPO must prepare for Sarbanes-Oxley Act compliance, including internal control over financial reporting certification and audit committee independence requirements.

Intellectual Property Considerations for Technology Investments

Chinese VC investors in US technology companies must address IP ownership and assignment provisions in investment documents. Startup companies typically require all founders and employees to assign inventions to the company through comprehensive IP assignment agreements. Investors should verify that IP assignment obligations extend to all company intellectual property, including patents, copyrights, trade secrets, and mask works. University technology licensing arrangements must be documented with clear ownership terms, field-of-use restrictions, and diligence obligations. Open-source software licenses used by portfolio companies require careful due diligence to identify copyleft license obligations, attribution requirements, and potential implications for proprietary code integration. Investment agreements should include representations and warranties regarding IP ownership, third-party infringement claims, trade secret protection measures, and data privacy compliance. The Bayh-Dole Act implications for government-funded research conducted at US universities should be assessed for technology startups licensing university inventions. Chinese investors should also consider the implications of the Defense Federal Acquisition Regulation Supplement clauses applicable to portfolio companies selling technology products or services to the US Department of Defense, which may restrict foreign ownership or require disclosure of foreign investment relationships.

Practical Recommendations for Chinese VC Limited Partners

Chinese limited partners investing in US venture capital funds should conduct thorough fund manager due diligence, including review of the fund's track record with Chinese investors, a compliance history assessment including SEC filings and examinations, the fund's CFIUS filing experience and policy framework for technology investments, the fund's approach to export control compliance in portfolio companies, and tax structuring for Chinese LPs including treaty eligibility and PFIC considerations. Side letter negotiations should address most favored nation status, key person provisions, co-investment rights, fee and carry arrangements, and LPAC representation. Chinese LPs should also verify the fund's data room access and reporting procedures, quarterly and annual financial reporting standards, portfolio company valuation methodologies, and GP coinvestment requirements.